Use the search parameters below to filter talks:

2013 - IPITA 2013 Congress (Monterey)

Parallel Session 2 on Clinical Autologous Islet Transplantation
25 September 2013  /  11:00 - 12:30
Results from 55 open and robot-assisted pancreatectomies with autologous islet transplantation for the prevention of surgically induced diabetes
Presenter: Horacio Rilo, United States

Mini-Oral Session 6 on Clinical Islet Transplantation - Engraftment and graft monitoring
26 September 2013  /  11:00 - 12:30
Clinical impact of allogenic islet transplantation in 55 patients under ATG induction therapy and Tacrolimus-MMF maintenance immunosuppression
Presenter: DaHae Lee, Belgium
Reversible, moderate and early alteration of kidney function in non-uremic type 1 diabetic islet recipients under tacrolimus-mycophenolate maintenance therapy
Presenter: Pieter Gillard, Belgium
Central Retinal Artery (CRA) flow velocity: Color Doppler Ultrasound (CDUS) assessment in type 1 diabetic patients after Kidney-Pancreas (KP), Kidney-Alone (KA) and Islet Transplantation Alone (ITA)
Presenter: Paola Maffi, Italy
Reassembly of alpha and beta cells of neo-islet tissues engineered in the subcutaneous space by islet-cell sheet transplantation in mice
Presenter: Hirofumi Shimizu, Japan
Functional imaging of the pancreatic graft by Positron Emission Tomography
Presenter: Lina Sjoberg, Sweden
Islet transplantation outcomes similar in islet after kidney vs. islet alone in T1D adjusted for disease: results from the Collaborative Islet Transplant Registry (CITR)
Presenter: Rodolfo Alejandro, United States
Failure to achieve normal metabolic response with ex vivo electroporation of the human proinsulin gene (p3MTChins) in primary murine hepatocytes for correction of NOD and STZ-induced diabetes.
Presenter: Garrett Roll, United States
Long acting GLP1 therapy in islet transplant recipients
Presenter: Eduardo Moraes Leao Peixoto, United States
Improvement in insulin sensitivity following human islet transplantation for type 1 diabetes: comparison of euglycemic clamp and minimal model approaches
Presenter: Michael Rickels, United States
Allogeneic pancreas for islet donor assessment for high islet product transplant rate and donor pancreas utilization in a Phase III clinical trial - A preliminary analysis
Presenter: Joshua Wilhelm, United States
Factors predictive of clinical outcomes following single islet allograft infusion in type 1 diabetes from the Collaborative Islet Transplant Registry
Presenter: Bernhard J. Hering, United States

Mini-Oral Session 7 on Islet Encapsulation, Immunology and Tolerance
26 September 2013  /  11:00 - 12:30
Tacrolimus inhibits the revascularization of isolated pancreatic islets.
Presenter: Ryuichi Nishimura, Japan
Co-encapsulation of glucagon-like peptide-1 secreting L cells improves microencapsulated islet function
Presenter: Alan Kerby, United Kingdom
Tolerance promoting therapies result in early restraint of T cell reactivity rather than conversion to a regulatory phenotype
Presenter: Ronald Gill, United States
Combined anti-CD154 and CD8 T cell depletion significantly prolongs islet isograft survival in diabetic NOD mice
Presenter: Adam Burrack, United States
Microfluidic Array with Integrated Oxygenation Control for Real-Time Live-Cell Imaging: Effect of Hypoxia on Physiology of Microencapsulated Pancreatic Islets
Presenter: Mohammad Nourmohammadzadeh, United States
The effect of cell-matrix interaction on encapsulated human islets
Presenter: Jeffrey Rawson, United States
Thin-film encapsulation devices for pancreatic islets
Presenter: Ryan Chang, United States
Effect of minimal immunomodulation on the biocompatibility of alginate microbeads implanted into the peritoneal cavity of cynomolgus monkeys
Presenter: Matthew Bochenek, United States

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice